IBRX insider trades & Congress trades
ImmunityBio, Inc.: public insider filings and Congress disclosures, in one place.
Bourse has recorded 2 open-market insider transactions in ImmunityBio, Inc. (IBRX) (0 purchases with code P and 2 sales with code S), the most recent on October 5, 2026.
In the last 90 days: 0 purchases by 0 insiders ($0) and 2 sales by 2 ($1.12M).
Members of Congress have disclosed 2 trades in IBRX (2 purchases, 0 sales), the latest transaction dated September 30, 2026. Congress filings can arrive up to 45 days after the trade.
Insider transactions
SEC Form 4, open-market purchases (P) and sales (S) only. Awards, option exercises and tax withholding are excluded. “After” shows the stock’s return over the month following the trade, where available.
| Date | Insider | Role | Type | Shares | Price | Value | After 1M |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | Simon Barry J. | – | Sell | 25,000 | $10.75 | $269K | – |
| Oct 2, 2026 | Cohen Cheryl | – | Sell | 81,056 | $10.50 | $851K | – |
Congress trades
Disclosures under the STOCK Act. Amounts are reported as ranges; some trades are made by a spouse or dependent child.
| Traded | Member | Party | Type | Amount | Disclosed | Filing |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Lisa McClain | house | Buy | $1,001 - $15,000 | Oct 12, 2026 | Source |
| Sep 28, 2026 | Lisa McClain | house | Buy | $1,001 - $15,000 | Oct 12, 2026 | Source |
Data as of November 8, 2026. Public filings only. A purchase or sale by a politician or an insider does not by itself imply any wrongdoing.
New to these filings? Read how to read a Form 4, how Congress trades are disclosed and what insider cluster buying means. Sources and limits are on the Methodology page.
See these filings as they land
Bourse collects Congress trades, SEC Form 4 insider filings and 13F fund holdings in one live feed, and flags insider buying clusters automatically. Free to start.
Bourse provides financial data and editorial information, parts of which are generated by AI. This page is for general education only. It is not personalised investment advice or a recommendation to buy or sell any financial instrument. Make your own decisions.